Search details
1.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38594880
2.
Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.
Acta Med Okayama
; 77(1): 65-70, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36849147
3.
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(1): 101-106, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32648165
4.
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer.
Jpn J Clin Oncol
; 51(2): 279-286, 2021 Feb 08.
Article
in English
| MEDLINE | ID: mdl-33049757
5.
Utility of immune checkpoint inhibitors in non-small-cell lung cancer patients with poor performance status.
Cancer Sci
; 111(10): 3739-3746, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32726470
6.
Erratum to: Impact of previous thoracic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer.
Jpn J Clin Oncol
; 51(8): 1348, 2021 Aug 01.
Article
in English
| MEDLINE | ID: mdl-34215885
7.
Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report.
J Gastrointest Oncol
; 15(1): 491-499, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38482223
8.
Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol.
Respir Med Case Rep
; 45: 101894, 2023.
Article
in English
| MEDLINE | ID: mdl-37485238
9.
Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer.
Respir Investig
; 61(5): 643-650, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37480603
10.
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance.
J Cancer Res Clin Oncol
; 149(8): 4933-4938, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36308525
11.
Selective cyclooxygenase-2 inhibitor prevents cisplatin-induced tumorigenesis in A/J mice.
Acta Med Okayama
; 66(3): 245-51, 2012.
Article
in English
| MEDLINE | ID: mdl-22729105
12.
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study.
Cancers (Basel)
; 14(24)2022 Dec 14.
Article
in English
| MEDLINE | ID: mdl-36551668
13.
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Acta Med Okayama
; 65(4): 259-63, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21860532
14.
The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression.
Eur J Cancer
; 149: 73-81, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33838391
15.
Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
J Cancer Res Clin Oncol
; 147(12): 3749-3755, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-33779840
16.
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol.
Thorac Cancer
; 12(5): 725-731, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33434415
17.
The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer.
Lung Cancer
; 139: 140-145, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31786476
18.
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Cancer Chemother Pharmacol
; 60(1): 53-9, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17009034
19.
Aberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancer.
Asian Pac J Cancer Prev
; 8(2): 221-4, 2007.
Article
in English
| MEDLINE | ID: mdl-17696735
20.
Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
Clin Lung Cancer
; 18(2): 245-249, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27847247